Cocrystal Pharma (COCP) Other Non-Current Liabilities (2011 - 2019)
Cocrystal Pharma (COCP) posted Other Non-Current Liabilities of $90000.0 for Q3 2019, down 26.83% sequentially from $123000.0 in Q2 2019, and down 43.4% YoY from $159000.0 in Q3 2018.
Cocrystal Pharma (COCP) Other Non-Current Liabilities (2011 - 2019) Analysis & Trends
Cocrystal Pharma has reported Other Non-Current Liabilities for 6 years, with the latest figure at $90000.0 in Q3 2019.
- Quarterly Other Non-Current Liabilities fell 43.4% year-over-year to $90000.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $90000.0 (down 43.4% YoY) and the FY2018 annual result came in at $263000.0, down 53.78% from the prior year.
- Other Non-Current Liabilities slipped to $90000.0 in Q3 2019 per COCP's latest filing, from $123000.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $4.1 million in Q4 2015 and troughed at $90000.0 in Q3 2019.
- A 5-year average of $972000.0 and a median of $416000.0 in 2017 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2018 and 2019: Other Non-Current Liabilities plunged 81.4% in 2018, then plunged 43.4% in 2019.
- Over 5 years, Other Non-Current Liabilities stood at $4.1 million in 2015, then slumped by 64.13% to $1.5 million in 2016, then slumped by 61.45% to $569000.0 in 2017, then slumped by 53.78% to $263000.0 in 2018, then slumped by 65.78% to $90000.0 in 2019.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $90000.0, $123000.0, and $163000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 90,000.00 |
| Jun 30, 2019 | 123,000.00 |
| Mar 31, 2019 | 163,000.00 |
| Dec 31, 2018 | 263,000.00 |
| Sep 30, 2018 | 159,000.00 |
| Dec 31, 2017 | 569,000.00 |
| Sep 30, 2017 | 855,000.00 |
| Dec 31, 2016 | 1.48 Mn |
| Sep 30, 2016 | 1.91 Mn |
| Dec 31, 2015 | 4.12 Mn |
| Jun 30, 2011 | -1,672.00 |